vs
Inspirato Inc（ISPO）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Inspirato Inc的1.3倍（$69.8M vs $55.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -8.1%，领先392.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -19.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -11.4%）
Inspirato Inc是一家高端旅行及酒店订阅服务供应商，主要面向北美高净值人群，提供精选豪华别墅租赁、专属度假村权益、定制化行程规划服务，同时也为企业客户提供高端员工差旅激励解决方案。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ISPO vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$55.5M
营收增速更快
RIGL
高出40.8%
-19.6%
净利率更高
RIGL
高出392.2%
-8.1%
两年增速更快
RIGL
近两年复合增速
-11.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.5M | $69.8M |
| 净利润 | $-4.5M | $268.1M |
| 毛利率 | 31.4% | 91.5% |
| 营业利润率 | -8.0% | 33.2% |
| 净利率 | -8.1% | 384.0% |
| 营收同比 | -19.6% | 21.2% |
| 净利润同比 | -204.4% | 1769.2% |
| 每股收益（稀释后） | $-0.36 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPORIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $55.5M | $69.5M | ||
| Q2 25 | $63.1M | $101.7M | ||
| Q1 25 | $65.9M | $53.3M | ||
| Q4 24 | $63.1M | $57.6M | ||
| Q3 24 | $69.1M | $55.3M | ||
| Q2 24 | $67.4M | $36.8M | ||
| Q1 24 | $80.2M | $29.5M |
净利润ISPORIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-4.5M | $27.9M | ||
| Q2 25 | $-5.3M | $59.6M | ||
| Q1 25 | $1.6M | $11.4M | ||
| Q4 24 | $-2.3M | $14.3M | ||
| Q3 24 | $4.3M | $12.4M | ||
| Q2 24 | $-8.7M | $-1.0M | ||
| Q1 24 | $1.3M | $-8.2M |
毛利率ISPORIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | 31.4% | 93.2% | ||
| Q2 25 | 27.5% | 95.6% | ||
| Q1 25 | 38.8% | 91.7% | ||
| Q4 24 | 34.7% | 89.9% | ||
| Q3 24 | 71.5% | 85.5% | ||
| Q2 24 | 24.0% | 92.4% | ||
| Q1 24 | 39.5% | 93.1% |
营业利润率ISPORIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | -8.0% | 40.9% | ||
| Q2 25 | -8.3% | 60.1% | ||
| Q1 25 | 2.5% | 23.9% | ||
| Q4 24 | -3.2% | 28.9% | ||
| Q3 24 | 9.8% | 25.4% | ||
| Q2 24 | -22.8% | 1.2% | ||
| Q1 24 | 3.0% | -23.6% |
净利率ISPORIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -8.1% | 40.2% | ||
| Q2 25 | -8.4% | 58.6% | ||
| Q1 25 | 2.5% | 21.5% | ||
| Q4 24 | -3.6% | 24.9% | ||
| Q3 24 | 6.3% | 22.5% | ||
| Q2 24 | -12.9% | -2.8% | ||
| Q1 24 | 1.6% | -27.9% |
每股收益（稀释后）ISPORIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $-0.36 | $1.46 | ||
| Q2 25 | $-0.42 | $3.28 | ||
| Q1 25 | $0.12 | $0.63 | ||
| Q4 24 | $0.98 | $0.82 | ||
| Q3 24 | $0.62 | $0.70 | ||
| Q2 24 | $-2.33 | $-0.06 | ||
| Q1 24 | $-0.18 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-134.0M | $391.5M |
| 总资产 | $228.3M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ISPORIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | $13.7M | $137.1M | ||
| Q2 25 | $16.7M | $108.4M | ||
| Q1 25 | $16.4M | $77.1M | ||
| Q4 24 | $21.8M | $77.3M | ||
| Q3 24 | $13.5M | $61.1M | ||
| Q2 24 | $18.8M | $49.1M | ||
| Q1 24 | $22.6M | $49.5M |
总债务ISPORIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ISPORIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $-134.0M | $117.6M | ||
| Q2 25 | $-129.7M | $81.9M | ||
| Q1 25 | $-125.2M | $18.6M | ||
| Q4 24 | $-129.9M | $3.3M | ||
| Q3 24 | $-134.6M | $-14.6M | ||
| Q2 24 | $-35.2M | $-29.9M | ||
| Q1 24 | $-27.5M | $-31.7M |
总资产ISPORIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $228.3M | $242.5M | ||
| Q2 25 | $252.6M | $206.7M | ||
| Q1 25 | $270.1M | $176.0M | ||
| Q4 24 | $273.9M | $164.0M | ||
| Q3 24 | $273.3M | $139.4M | ||
| Q2 24 | $301.7M | $128.4M | ||
| Q1 24 | $313.0M | $126.5M |
负债/权益比ISPORIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-3.0M | — |
| 自由现金流率自由现金流/营收 | -5.4% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-31.2M | — |
8季度趋势，按日历期对齐
经营现金流ISPORIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $-2.2M | $24.0M | ||
| Q2 25 | $1.1M | $30.5M | ||
| Q1 25 | $-6.6M | $-893.0K | ||
| Q4 24 | $-15.8M | $14.5M | ||
| Q3 24 | $-13.7M | $21.7M | ||
| Q2 24 | $-1.8M | $302.0K | ||
| Q1 24 | $-7.2M | $-5.0M |
自由现金流ISPORIGL
| Q4 25 | — | — | ||
| Q3 25 | $-3.0M | — | ||
| Q2 25 | $468.0K | — | ||
| Q1 25 | $-7.5M | — | ||
| Q4 24 | $-21.2M | — | ||
| Q3 24 | $-14.8M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-8.5M | — |
自由现金流率ISPORIGL
| Q4 25 | — | — | ||
| Q3 25 | -5.4% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | -11.4% | — | ||
| Q4 24 | -33.7% | — | ||
| Q3 24 | -21.5% | — | ||
| Q2 24 | -5.5% | — | ||
| Q1 24 | -10.6% | — |
资本支出强度ISPORIGL
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 1.6% | — |
现金转化率ISPORIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | -4.09× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -3.16× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -5.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
RIGL
暂无分部数据
